Search

You searched for "lashes"

2014 results found

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | Duncan Marston | EYE - Vitreo-Retinal, EYE - Glaucoma

Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...

Q&A: Mr Goel and Mr Loomba on alcohol delamination and phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome

14 June 2023 | Aina Pons, Abhinav Loomba, Siddharth Goel | EYE - Cornea

Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...

Pathophysiology of diabetic macular oedema: why combination therapy may be better

1 October 2015 | Winfried MK Amoaku | EYE - Vitreo-Retinal

The prevalence of diabetes has continued to increase over the years. It is currently estimated that there are 382 million with diabetes worldwide in 2013, and that this figure is expected to rise to 592 million by 2035 [1]. In...

What's trending Oct/Nov 2023

4 October 2023 | Amit Dhalla | EYE - General

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Hello A big hello to those reading. It’s my absolute pleasure to take on the mantel of section editor of the...

Report: UKEGS 2024

29 October 2024 | UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham

It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

The management of retinal vein occlusions: a summary

1 February 2015 | Amy-lee Shirodkar | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General

Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...

Ocular manifestations of multiple sclerosis: an overview

1 December 2022 | Alice Ditchfield, Ali Yagan | EYE - Neuro-ophthalmology, EYE - Pathology

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS), in which there is dissemination of lesions in time (two or more clinical events) and space (multiple lesions seen on brain and spinal imaging). The pathophysiology...

Progressive myelination of the retinal nerve fibre layer: Acquired or incidental?

4 August 2025 | Modupe Sodeinde, Sohaib Rufai, Straton Tyradellis, Nasrul Nijam, Nagini Sarvananthan, Samira Anwar-Bhatti | EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Paediatrics

*Co-first authors.Myelinated retinal nerve fibres are retinal nerve fibres encased by a myelin sheath, located anterior to the lamina cribrosa [1]. First described by Virchow in 1856, a myelinated retinal nerve fibre layer (RNFL) appears as a whitish, feathery patch...

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

1 February 2017 | Usha Chakravarthy (Prof) | EYE - Vitreo-Retinal

There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...

«
54
55
56
57
58
59 (current)
60
61
62
63
64
»